• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Abbott India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500488
INE358A01014
2246.6776471
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ABBOTINDIA
38.1
59124.19
EPS(TTM)
Face Value()
Div & Yield %
730.36
10
1.71
 

Albert David reports standalone net loss of Rs 21.43 crore in the March 2026 quarter
May 13,2026
Net Loss of Albert David reported to Rs 21.43 crore in the quarter ended March 2026 as against net loss of Rs 10.33 crore during the previous quarter ended March 2025. Sales rose 14.65% to Rs 85.86 crore in the quarter ended March 2026 as against Rs 74.89 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.49 crore in the year ended March 2026 as against net profit of Rs 17.20 crore during the previous year ended March 2025. Sales declined 3.52% to Rs 333.60 crore in the year ended March 2026 as against Rs 345.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales85.8674.89 15 333.60345.77 -4
OPM %3.21-6.34 -1.640.87 -
PBDT-22.51-9.99 -125 10.2832.19 -68
PBT-25.23-11.81 -114 0.5225.22 -98
NP-21.43-10.33 -107 -1.4917.20 PL